课题基金 / 基金详情

GitLife 2.0: Utilising next generation digital technologies to deliver twenty-fold improvement to a unique version control system, enabling SynBio innovations in net zero and healthcare.

GitLife 2.0: Utilising next generation digital technologies to deliver twenty-fold improvement to a unique version control system, enabling SynBio innovations in net zero and healthcare.
GitLife 2.0:利用下一代数字技术为独特的版本控制系统提供二十倍的改进,从而实现 SynBio 在净零排放和医疗保健领域的创新。
批准号:
10077100
负责人:
金额:
$31.77万
依托单位:
依托单位国家:
英国
项目类别:
Investment Accelerator
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Synthetic Biology (SynBio) is the application of engineering principles to biology. Synthetic Biologists think of proteins as machines, composed of multiple different components, each encoded by genes or parts of genes. By rearranging genes, they can make proteins with new functions. SynBio also uses computer modelling heavily, mapping what genes should go where in designs for new biological machine. SynBio aims to solve problems in energy, food production and human health by optimising biological machines. Lots of grant funding and private investment has poured into SynBio research. However, there are no reliable systems to match engineered organisms with records of how they were constructed. Because commercial competitors can copy engineered organisms relatively easily, many new ideas fail to be commercialised. It is also critical that companies using SynBio can provide government agencies who regulate SynBio with absolute proof that they are using the strain they say they are.GitLife Biotech (GLB) has developed a system that can insert 'barcode' sequences of DNA into an organism's genome. Anyone can find out the sequence of this barcode and use it to see what a particular strain is. In this project, they want to make this system more secure by using a computer coding system called Elliptical Curve cryptography. They also want to demonstrate that they can insert several barcodes into a strain at different locations. The DNA sequence of these barcodes, combined with their location makes it practically impossible for anyone wanting to copy the strain to remove these identification marks.GLB plans to launch this system onto the market in late 2023\. An investment company called SFC Capital are interested in making an equity investment, provided that GLB can secure a grant to cover some of the costs of making their technology more secure and faster to apply.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
同带泵浦2.0μm高功率单频光纤激光器研究
建立基于CRISPR/Cas12a的基因突变检测系统EasyCatch v2.0实现急性髓系白血病快速诊断和动态监测
  • 批准号:
    82300264
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘银
  • 依托单位:
多元复合微合金化2.0GPa热成形钢氢致延迟开裂性能及其调控机理研究
基于2.0μm光纤激光器的光子晶体光纤有序微结构调控设计及激光特性研究